Related Experiment Video
Updated: Jul 9, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer
Wen Yue1, Quanhong Sun, Sanja Dacic
1Department of Pharmacology.
Abstract:
Although the oncogenic role of the Wnt/beta-catenin pathway is well defined, it remains unclear how this pathway is aberrantly activated in lung cancer. We found that Dickkopf (Dkk)-3, a member of Dkk family of Wnt antagonists, is frequently inactivated in lung cancer and plays a role in suppressing lung cancer cell growth through inhibition of beta-catenin/T-cell factor (TCF)-4 signaling. Dkk3 is the only Dkk family member abundantly expressed in normal lung, but silenced by promoter hypermethylation in a large fraction of lung cancer cell lines and lung tumors. Downregulation of Dkk3 was correlated with tumor progression and expression of nuclear beta-catenin in lung tumors. Ectopic expression of Dkk3 in lung cancer cells with Dkk3 hypermethylation induced apoptosis and inhibited TCF-4 activity as well as nuclear accumulation of beta-catenin and expression of TCF-4 targets c-Myc and cyclin D1. Furthermore, small interference RNA knock down of Dkk3 in cells lacking Dkk3 hypermethylation was sufficient to promote cell proliferation, beta-catenin nuclear translocation and expression of c-Myc. These observations suggested that epigenetic inactivation of Dkk3 activates the Wnt/beta-catenin pathway, thereby promoting the growth of lung cancer cells.
Insights
Dickkopf-3 (Dkk3) inactivation promotes lung cancer growth by activating the Wnt/beta-catenin pathway. Epigenetic silencing of Dkk3 in lung tumors leads to uncontrolled cell proliferation and tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- The Wnt/beta-catenin pathway is crucial in cellular processes but its aberrant activation drives lung cancer.
- Mechanisms of Wnt/beta-catenin pathway activation in lung cancer remain incompletely understood.
Purpose of the Study:
- To investigate the role of Dickkopf-3 (Dkk3) in lung cancer pathogenesis.
- To determine if Dkk3 inactivation contributes to Wnt/beta-catenin pathway activation in lung tumors.
Main Methods:
- Analysis of Dkk3 expression and promoter methylation in lung cancer cell lines and tumors.
- Functional studies involving ectopic Dkk3 expression and small interference RNA (siRNA) knockdown in lung cancer cells.
- Assessment of Wnt/beta-catenin pathway activity, including beta-catenin/T-cell factor (TCF)-4 signaling and target gene expression (c-Myc, cyclin D1).
Main Results:
- Dkk3, a Wnt antagonist normally abundant in lung tissue, is frequently silenced by promoter hypermethylation in lung cancer.
- Dkk3 downregulation correlates with lung tumor progression and nuclear beta-catenin accumulation.
- Restoring Dkk3 expression induces apoptosis and inhibits Wnt/beta-catenin signaling, while Dkk3 knockdown promotes proliferation and pathway activation.
Conclusions:
- Epigenetic inactivation of Dkk3 is a key mechanism for Wnt/beta-catenin pathway activation in lung cancer.
- Dkk3 acts as a tumor suppressor in lung cancer by inhibiting beta-catenin/TCF-4 signaling.
- Targeting Dkk3 or the Wnt/beta-catenin pathway may offer therapeutic strategies for lung cancer.
Related Concept Videos
Canonical Wnt Signaling Pathway
TGF - β Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Regulation of Angiogenesis and Blood Supply
